SEC Form 4 · accession 0000899243-16-015040
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Sirgo
Officer — President and CEO · Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 6:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Feb 29, 2016 | A | 275,000 | A | — | Mar 1, 2019 | Common Stock | 275,000 | 275,000 | D |
Explanation of responses
- F1The RSUs were issued to the Reporting Person on February 29, 2016, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. One-third of the RSUs will vest on each of (i) March 1, 2017, (ii) March 1, 2018 and (iii) March 1, 2019. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.